Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.